FAIRFAX, Va., Oct. 23 -- George Mason University issued the following news release:
A new research collaboration between George Mason University and Virginia Commonwealth University (VCU) aims to improve understanding of peripheral neuropathy, a painful and often life-altering side effect experienced by breast cancer survivors involving damage to the nerves that can interrupt daily function.
With a $200,000 grant from the Commonwealth Health Research Board, the project, "Proteomic and Neuroimmune Signatures of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer," focuses on chemotherapy-induced peripheral neuropathy (CIPN), a common side effect of chemotherapy that affects more than 50% of patients, with up to 30% experiencing per...